$ADMA 3/ FDA approved drugs, pro forma cash ~ $110 million, $50 million in inventory and talking to key players on COVID. There was alot of positive packed into that CC. Encourage everyone to digest it. I believe on those fundamentals alone this stock is significantly undervalued, COVID or no COVID. With COVID involvement I see $10+, but I see that without COVID as well. Only difference is the speed at which that spike happens.